AJOVista LLC Acquires New Stake in Lam Research Co. (NASDAQ:LRCX)

AJOVista LLC bought a new position in shares of Lam Research Co. (NASDAQ:LRCXFree Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 130 shares of the semiconductor company’s stock, valued at approximately $102,000.

A number of other institutional investors also recently modified their holdings of LRCX. Valued Wealth Advisors LLC bought a new position in Lam Research in the fourth quarter valued at $30,000. Orion Capital Management LLC acquired a new stake in shares of Lam Research in the third quarter valued at about $25,000. BluePath Capital Management LLC acquired a new position in Lam Research during the third quarter valued at approximately $28,000. Asset Dedication LLC grew its stake in Lam Research by 56.7% in the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 17 shares in the last quarter. Finally, Rakuten Securities Inc. acquired a new position in shares of Lam Research during the 4th quarter worth approximately $38,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Price Performance

Shares of LRCX traded up $24.85 during trading hours on Friday, reaching $908.53. The stock had a trading volume of 875,385 shares, compared to its average volume of 1,105,338. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.84 and a current ratio of 2.82. Lam Research Co. has a 12 month low of $507.19 and a 12 month high of $1,007.39. The stock has a market capitalization of $119.11 billion, a PE ratio of 33.41, a PEG ratio of 2.82 and a beta of 1.51. The company’s 50-day moving average is $941.31 and its two-hundred day moving average is $817.83.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its earnings results on Wednesday, April 24th. The semiconductor company reported $7.79 EPS for the quarter, beating the consensus estimate of $7.26 by $0.53. The firm had revenue of $3.79 billion during the quarter, compared to the consensus estimate of $3.72 billion. Lam Research had a return on equity of 45.96% and a net margin of 25.35%. The business’s quarterly revenue was down 2.0% on a year-over-year basis. During the same period last year, the company earned $6.99 earnings per share. Research analysts expect that Lam Research Co. will post 29.62 EPS for the current year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were paid a dividend of $2.00 per share. This represents a $8.00 annualized dividend and a dividend yield of 0.88%. The ex-dividend date was Tuesday, March 12th. Lam Research’s payout ratio is currently 29.42%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on LRCX shares. Mizuho raised their target price on shares of Lam Research from $935.00 to $960.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. The Goldman Sachs Group upped their price target on shares of Lam Research from $700.00 to $912.00 and gave the company a “buy” rating in a research note on Thursday, January 25th. Citigroup increased their target price on shares of Lam Research from $975.00 to $1,025.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Lam Research in a research report on Thursday, April 11th. They issued a “hold” rating and a $1,000.00 price target for the company. Finally, Wells Fargo & Company raised their price objective on Lam Research from $930.00 to $980.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 2nd. Seven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $950.85.

Get Our Latest Stock Report on LRCX

Insider Transactions at Lam Research

In related news, SVP Seshasayee Varadarajan sold 5,500 shares of the firm’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the completion of the transaction, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at approximately $20,380,648.95. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, EVP Patrick J. Lord sold 60 shares of Lam Research stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $921.54, for a total value of $55,292.40. Following the completion of the transaction, the executive vice president now directly owns 4,454 shares of the company’s stock, valued at approximately $4,104,539.16. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $922.41, for a total value of $5,073,255.00. Following the transaction, the senior vice president now owns 22,095 shares in the company, valued at $20,380,648.95. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 7,089 shares of company stock worth $6,614,781. Company insiders own 0.32% of the company’s stock.

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.